Every material Form 8-K Edgewell Personal Care filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Edgewell Personal Care reported fourth-quarter and fiscal 2024 results for the year ended September 30, 2024, and gave a fiscal 2025 outlook. Fourth-quarter net sales fell 3.1% and GAAP diluted EPS dropped to $0.17 from $0.58, while full-year net sales rose 0.1% and adjusted EPS rose 18%. The fiscal 2025 outlook calls for adjusted EPS of $3.15 to $3.35, which would be growth from $3.05, but the weak quarter and higher restructuring charges weigh on near-term results.
Q4 fiscal 2024 net sales were $517.6 million, down 3.1%; GAAP diluted EPS was $0.17 versus $0.58 a year earlier
Fiscal 2024 net sales were $2,253.7 million, up 0.1%; GAAP diluted EPS was $1.97 versus $2.21, and adjusted EPS was $3.05, up 18%
Fiscal 2025 outlook: adjusted EPS of $3.15 to $3.35 and organic net sales growth of approximately 1% to 3%
Quarterly cash dividend of $0.15 per share declared October 31, 2024, payable January 8, 2025
Edgewell Personal Care's board increased its size from 10 to 11 members and elected Stephanie Stahl as a director effective September 10, 2024, filling the new seat. Stahl will serve on the Audit Committee and the Human Capital and Compensation Committee, and her term runs to the 2025 annual meeting. The filing discloses no financial results, and the change is an administrative board addition.
Board expanded from 10 to 11 members, effective September 10, 2024
Stephanie Stahl joins the Audit Committee and Human Capital and Compensation Committee
Stahl's term expires at the 2025 Annual Meeting of Shareholders
Stahl is a Senior Advisor to Boston Consulting Group and serves on the boards of Carter's, Dollar Tree and Newell Brands
Edgewell Personal Care named Daniel Sullivan Chief Operating Officer and Francesca Weissman as Chief Financial Officer effective December 1, 2024, and said North America president Eric O'Toole will step aside under a separation agreement effective November 15, 2024. The changes were announced alongside third-quarter fiscal 2024 results, in which the company said it raised its fiscal 2024 Adjusted EBITDA and Adjusted EPS outlook.
Daniel J. Sullivan appointed Chief Operating Officer effective August 6, 2024; he remains CFO until December 1, 2024.
Francesca Weissman becomes CFO effective December 1, 2024, succeeding Sullivan.
The company raised its fiscal 2024 Adjusted EBITDA and Adjusted EPS outlook; the filing does not state the new figures.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Edgewell Personal Care filing is on SEC EDGAR ↗. 8-K briefs of other companies →